Temozolomide for High Grade Glioma
Author:
Publisher
John Wiley & Sons, Ltd
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007415/epdf/full
Reference29 articles.
1. Randomised Phase II study of Temozolomide and Radiotherapy Compared with Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme;Athanassiou;Journal of Clinical Oncology,2005
2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma;Stupp;New England Journal of Medicine,2005
3. Health-related quality of life in patients with glioblastoma: A randomised controlled trial;Taphoorn;Lancet Oncology,2005
4. Randomized trial of temodal (TEM) vs. procarbazine (PCB) in glioblastoma multiforme (GBM) at first relapse.;Yung;Proceedings of the American Society of Clinical Oncology,2000
5. Multicentre CRC Phase II trial of temozolomide in recurrent or progressive high-grade glioma.;Bower;Cancer, Chemotherapy and Pharmacology,1997
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effects of the combination of temozolomide and Eribulin on T98G human glioblastoma cell line: an ultrastructural study;Ultrastructural Pathology;2024-06-25
2. Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells;International Journal of Molecular Sciences;2024-05-12
3. Repurposing synthetic and natural derivatives induces apoptosis in an orthotopic glioma‐induced xenograft model by modulating WNT/β‐catenin signaling;Fundamental & Clinical Pharmacology;2023-07-17
4. Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients;Psychology, Health & Medicine;2023-06-04
5. All-Nontoxic Fluorescent Probe for Biothiols and Its Clinical Applications for Real-Time Glioblastoma Visualization;ACS Sensors;2023-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3